Breast Imaging Technologies Market Is Predicted To Increase at a Valuation Of US$ 6.6 Billion By 2027

The American Cancer Society reports that almost half of all women over the age of 62 are diagnosed with breast cancer. Doctors and cancer surgeons employ breast imaging technologies to diagnose breast shape, cell composition, and tumors. Breast imaging has been crucial in identifying cancer cells and lumps, which has helped in lowering the death rate of breast-related illnesses globally.

The global demand for breast imaging technologies is anticipated expand rapidly at 7% CAGR and reach a valuation of US$ 6.6 billion by 2027. Market growth is mainly attributed to the rising population of women over 45 who are at an increased risk of developing breast cancer.

𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐚 𝐒𝐚𝐦𝐩𝐥𝐞 𝐂𝐨𝐩𝐲 𝐨𝐟 𝐓𝐡𝐢𝐬 𝐑𝐞𝐩𝐨𝐫𝐭:https://www.factmr.com/connectus/sample?flag=S&rep_id=7709?PJ 

Market expansion is greatly supported by the rapid technological advances in breast screening, the growing number of conferences held around the world to raise awareness of the advantages of early detection and diagnosis, and growing public and private investments to meet the rising demand for breast cancer screening.

𝐑𝐢𝐬𝐢𝐧𝐠 𝐃𝐞𝐦𝐚𝐧𝐝 𝐟𝐨𝐫 𝐃𝐢𝐚𝐠𝐧𝐨𝐬𝐢𝐬 𝐨𝐟 𝐁𝐫𝐞𝐚𝐬𝐭-𝐫𝐞𝐥𝐚𝐭𝐞𝐝 𝐀𝐛𝐧𝐨𝐫𝐦𝐚𝐥𝐢𝐭𝐢𝐞𝐬

According to Fact.MR, a market research and competitive intelligence provider, sales of breast imaging technologies are expected to increase at a CAGR of 7% from 2022 to 2027.

The risks of breast cancer have considerably grown in recent years due to factors such as the widespread use of hormone replacement therapy after menopause, numerous reproductive issues, and hormonal changes. Breast cancer screening and diagnosis are becoming increasingly popular worldwide due to the rising incidence of breast cancer.

Breast-related abnormalities are diagnosed using breast imaging technologies. Doctors and tumor surgeons can diagnose breast anatomy, cell composition, tumors, and other internal breast components using breast imaging technologies.

𝐊𝐞𝐲 𝐓𝐚𝐤𝐞𝐚𝐰𝐚𝐲𝐬 𝐟𝐫𝐨𝐦 𝐌𝐚𝐫𝐤𝐞𝐭 𝐒𝐭𝐮𝐝𝐲

• Demand for breast imaging technologies is expected to rise at a CAGR of 7% through 2027.

• The global breast imaging technologies market is currently valued at US$ 4.7 billion.

• The market in Canada is anticipated to expand at a CAGR of 6.5% over the forecast period.

• Demand for non-ionizing technologies is predicted to increase at a CAGR of 6.9% from 2022 to 2027.

• The market in Germany is set to increase at a CAGR of 4.5% through 2027.

𝐒𝐞𝐠𝐦𝐞𝐧𝐭𝐬 𝐨𝐟 𝐁𝐫𝐞𝐚𝐬𝐭 𝐈𝐦𝐚𝐠𝐢𝐧𝐠 𝐓𝐞𝐜𝐡𝐧𝐨𝐥𝐨𝐠𝐢𝐞𝐬 𝐈𝐧𝐝𝐮𝐬𝐭𝐫𝐲 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡

• 𝗕𝘆 𝗧𝘆𝗽𝗲 :

• Ionizing Technologies
• Non-ionizing Technologies

• 𝗕𝘆 𝗘𝗻𝗱 𝗨𝘀𝗲𝗿:

• Hospitals
• Diagnostic Imaging Centers
• Breast Care Centers
• Others

•𝗕𝘆 𝗥𝗲𝗴𝗶𝗼𝗻 :

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

𝐖𝐢𝐧𝐧𝐢𝐧𝐠 𝐒𝐭𝐫𝐚𝐭𝐞𝐠𝐲

Leading companies are putting more efforts in research and development to create innovative breast imaging technologies. Top market participants are focused on the development of hybrid imaging systems.

𝐅𝐨𝐫 𝐢𝐧𝐬𝐭𝐚𝐧𝐜𝐞,

• GE Healthcare and partnered with the National Cancer Center Singapore. By utilizing artificial intelligence and word processing, this collaboration aims to encourage the prospect of more customized cancer treatment alternatives while also giving patients the chance to analyze clinically important information.

• In 2022, a novel breast imaging modality was introduced by Seno Medical. Using non-invasive ultrasound technology this system assists doctors in identifying benign and malignant breast lesions and provides data on breast lesions in real-time.

𝐂𝐨𝐦𝐩𝐞𝐭𝐢𝐭𝐢𝐯𝐞 𝐋𝐚𝐧𝐝𝐬𝐜𝐚𝐩𝐞

Well-established organizations are implementing innovations and enhancements to improve breast cancer services as the healthcare sector looks for new strategies to provide access to high-quality care. Mid-size to smaller businesses are expanding their market presence by launching new items and minimizing the adverse effects of the treatments due to technological advancements and product improvements.

𝐅𝐨𝐫 𝐢𝐧𝐬𝐭𝐚𝐧𝐜𝐞 :

• In 2020, Hologic, Inc. revealed the commercial availability of its AI detection tool to assist radiologists in finding tumors in breast tomosynthesis images. The company claims that it will improve patient experience and enhance cancer diagnosis.

𝐌𝐨𝐫𝐞 𝐕𝐚𝐥𝐮𝐚𝐛𝐥𝐞 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬 𝐨𝐧 𝐎𝐟𝐟𝐞𝐫

Fact.MR, in its new offering, presents an unbiased analysis of the global breast imaging technologies market, presenting historical demand data (2017-2021) and forecast statistics for the period of 2022-2027.

The study divulges essential insights on the market on the basis of type (ionizing technologies, non-ionizing technologies) and end user (hospitals, diagnostic imaging centers, breast care centers, others), across five major regions of the world (North America, Europe, Asia Pacific, Latin America, and MEA).

𝐆𝐞𝐭 𝐂𝐮𝐬𝐭𝐨𝐦𝐢𝐳𝐚𝐭𝐢𝐨𝐧 𝐨𝐧 𝐭𝐡𝐢𝐬 𝐑𝐞𝐩𝐨𝐫𝐭 𝐟𝐨𝐫 𝐒𝐩𝐞𝐜𝐢𝐟𝐢𝐜 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐒𝐨𝐥𝐮𝐭𝐢𝐨𝐧𝐬:https://www.factmr.com/connectus/sample?flag=RC&rep_id=7709?PJ

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E Mail : sales@factmr.com

Fact.MR is a market research and consulting agency with deep expertise in emerging market intelligence. Spanning a wide range - from automotive & industry 4.0 to healthcare, technology, chemical and materials, to even the most niche categories.

This release was published on openPR.